Stock prices jumped yesterday on the announcement that Sprint and T-Mobile resumed discussions of a merger. A merger of the two companies would combine the third- and fourth-largest U.S. wireless providers.
LVMH owns luxury brands from Louis Vuitton to Moet champagne and it now plans to sell watches. It will acquire a major piece of Italian jeweler Bulgari for $5.2 billion. Stephen Beard explains.
The combined German and New York Stock Exchange must now find a suitable name for the newly merged trading floor. And as Stephen Beard explains, instead of using a brand consultant, the new exchange is going the social media route for suggestions.
French pharmaceutical company Sanofi-Aventis will pay more than $20.1 billion for U.S. biotech firm Genzyme. Sanofi will pay $74 per Genzyme share once the deal closes in the second quarter of 2011.
Wednesday brought an end to the long-awaited deal between French pharmaceutical company Sanofi-Aventis and the U.S. biotech firm Genzyme. Sanofi will buy Genzyme for at least $20.1 billion. But the number could go higher if Genzym's drugs-in-development succeed when they go to market, as Eve Troeh explains.
The parent company for the New York Stock Exchange has agreed to a merger with Germany's Deutsche Borse, pending regulatory approval. The deal will create the largest exchange for stocks and derivatives in the world. Heidi Moore explains.
The Wall Street Journal reports a U.S. government panel will recommend that President Obama veto a bid by China's Huawai Technologies Co. to buy the assets of Bay Area developer 3Leaf Systems. Rob Schmitz reports.
